These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 12815042)
21. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors. Li C; Zhu NL; Tan RC; Ballard PL; Derynck R; Minoo P J Biol Chem; 2002 Oct; 277(41):38399-408. PubMed ID: 12161428 [TBL] [Abstract][Full Text] [Related]
22. The functional interaction between the paired domain transcription factor Pax8 and Smad3 is involved in transforming growth factor-beta repression of the sodium/iodide symporter gene. Costamagna E; García B; Santisteban P J Biol Chem; 2004 Jan; 279(5):3439-46. PubMed ID: 14623893 [TBL] [Abstract][Full Text] [Related]
24. CHIP controls the sensitivity of transforming growth factor-beta signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation. Xin H; Xu X; Li L; Ning H; Rong Y; Shang Y; Wang Y; Fu XY; Chang Z J Biol Chem; 2005 May; 280(21):20842-50. PubMed ID: 15781469 [TBL] [Abstract][Full Text] [Related]
25. Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3. Higashi K; Inagaki Y; Fujimori K; Nakao A; Kaneko H; Nakatsuka I J Biol Chem; 2003 Oct; 278(44):43470-9. PubMed ID: 12917425 [TBL] [Abstract][Full Text] [Related]
26. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Sachdev S; Bruhn L; Sieber H; Pichler A; Melchior F; Grosschedl R Genes Dev; 2001 Dec; 15(23):3088-103. PubMed ID: 11731474 [TBL] [Abstract][Full Text] [Related]
27. TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling. Felici A; Wurthner JU; Parks WT; Giam LR; Reiss M; Karpova TS; McNally JG; Roberts AB EMBO J; 2003 Sep; 22(17):4465-77. PubMed ID: 12941698 [TBL] [Abstract][Full Text] [Related]
28. Evidence for a role of MSK1 in transforming growth factor-beta-mediated responses through p38alpha and Smad signaling pathways. Abécassis L; Rogier E; Vazquez A; Atfi A; Bourgeade MF J Biol Chem; 2004 Jul; 279(29):30474-9. PubMed ID: 15133024 [TBL] [Abstract][Full Text] [Related]
29. Interaction of Smad3 and SRF-associated complex mediates TGF-beta1 signals to regulate SM22 transcription during myofibroblast differentiation. Qiu P; Feng XH; Li L J Mol Cell Cardiol; 2003 Dec; 35(12):1407-20. PubMed ID: 14654367 [TBL] [Abstract][Full Text] [Related]
30. Cross-talk between the p42/p44 MAP kinase and Smad pathways in transforming growth factor beta 1-induced furin gene transactivation. Blanchette F; Rivard N; Rudd P; Grondin F; Attisano L; Dubois CM J Biol Chem; 2001 Sep; 276(36):33986-94. PubMed ID: 11448947 [TBL] [Abstract][Full Text] [Related]
31. Transactivation properties of c-Myb are critically dependent on two SUMO-1 acceptor sites that are conjugated in a PIASy enhanced manner. Dahle Ø; Andersen TØ; Nordgård O; Matre V; Del Sal G; Gabrielsen OS Eur J Biochem; 2003 Mar; 270(6):1338-48. PubMed ID: 12631292 [TBL] [Abstract][Full Text] [Related]
32. Transcriptional activation of mouse mast cell Protease-7 by activin and transforming growth factor-beta is inhibited by microphthalmia-associated transcription factor. Funaba M; Ikeda T; Murakami M; Ogawa K; Tsuchida K; Sugino H; Abe M J Biol Chem; 2003 Dec; 278(52):52032-41. PubMed ID: 14527958 [TBL] [Abstract][Full Text] [Related]
33. Smad7 is a TGF-beta-inducible attenuator of Smad2/3-mediated inhibition of embryonic lung morphogenesis. Zhao J; Crowe DL; Castillo C; Wuenschell C; Chai Y; Warburton D Mech Dev; 2000 May; 93(1-2):71-81. PubMed ID: 10781941 [TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2. Song K; Cornelius SC; Reiss M; Danielpour D J Biol Chem; 2003 Oct; 278(40):38342-51. PubMed ID: 12876289 [TBL] [Abstract][Full Text] [Related]
35. A nuclear antagonistic mechanism of inhibitory Smads in transforming growth factor-beta signaling. Bai S; Cao X J Biol Chem; 2002 Feb; 277(6):4176-82. PubMed ID: 11711531 [TBL] [Abstract][Full Text] [Related]
36. Regulation of Smad7 promoter by direct association with Smad3 and Smad4. Nagarajan RP; Zhang J; Li W; Chen Y J Biol Chem; 1999 Nov; 274(47):33412-8. PubMed ID: 10559222 [TBL] [Abstract][Full Text] [Related]
37. Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. Ebisawa T; Fukuchi M; Murakami G; Chiba T; Tanaka K; Imamura T; Miyazono K J Biol Chem; 2001 Apr; 276(16):12477-80. PubMed ID: 11278251 [TBL] [Abstract][Full Text] [Related]
38. PIASy-mediated repression of the androgen receptor is independent of sumoylation. Gross M; Yang R; Top I; Gasper C; Shuai K Oncogene; 2004 Apr; 23(17):3059-66. PubMed ID: 14981544 [TBL] [Abstract][Full Text] [Related]
39. Protein inhibitor of activated STAT, PIASy regulates α-smooth muscle actin expression by interacting with E12 in mesangial cells. Torikoshi K; Abe H; Matsubara T; Hirano T; Ohshima T; Murakami T; Araki M; Mima A; Iehara N; Fukatsu A; Kita T; Arai H; Doi T PLoS One; 2012; 7(7):e41186. PubMed ID: 22829926 [TBL] [Abstract][Full Text] [Related]
40. Roles of autocrine TGF-beta receptor and Smad signaling in adipocyte differentiation. Choy L; Skillington J; Derynck R J Cell Biol; 2000 May; 149(3):667-82. PubMed ID: 10791980 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]